<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02846597</url>
  </required_header>
  <id_info>
    <org_study_id>NICU MUCH 2016</org_study_id>
    <nct_id>NCT02846597</nct_id>
  </id_info>
  <brief_title>Proper Pressure and Duration of Sustained Lung Inflation in Preterm Infants</brief_title>
  <official_title>Sustained Lung Inflation at Birth for Preterm Infants at Risk of Respiratory Distress Syndrome: the Proper Pressure and Duration: Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University Children Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University Children Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The appropriate pressure and duration needed for sustained lung inflation in preterm infants&#xD;
      at risk of respiratory distress syndrome have not been well evaluated. We aim for evaluating&#xD;
      two different pressures, 20 and 15 cm H2O, for two different duration, 10 and 20 seconds,&#xD;
      during the application of sustained lung inflation in the resuscitation of preterm infants&#xD;
      with respiratory distress in the delivery room.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a randomized prospective pilot study in Mansoura University Hospital then&#xD;
      the cases were followed at Neonatal Intensive Care Unit in Mansoura University Children&#xD;
      Hospital, Mansoura, Egypt.&#xD;
&#xD;
      Preterm infants born equal to or less than 32 weeks gestation with respiratory distress&#xD;
      syndrome will be included in the study.&#xD;
&#xD;
      We aim to study the proper pressure and duration of sustained lung inflation in the delivery&#xD;
      room.&#xD;
&#xD;
      Preterm infants will be divided into 5 groups:&#xD;
&#xD;
        1. Group 1 (Control group). In this group preterm infants will not be treated with&#xD;
           sustained lung inflation and in stead will receive regular respiratory care&#xD;
&#xD;
        2. Group 2 (High pressure for long duration group). Preterm infants in this group will be&#xD;
           treated with sustained lung inflation at pressure of 20 cm H2O for 20 seconds&#xD;
&#xD;
        3. Group 3 (High pressure for short duration group). Preterm infants in this group will be&#xD;
           treated with sustained lung inflation at pressure of 20 cm H2O for 10 seconds.&#xD;
&#xD;
        4. Group 4 (Low pressure for long duration group). Preterm infants in this group will be&#xD;
           treated with sustained lung inflation at pressure of 15 cm H2O for 20 seconds.&#xD;
&#xD;
        5. Group 5 (Low pressure for short duration group). Preterm infants in this group will be&#xD;
           treated with sustained lung inflation at pressure of 15 cm H2O for 10 seconds&#xD;
&#xD;
      Sustained lung inflation will be delivered using the T - piece ventilator (Neopuff infant&#xD;
      resuscitator; Fisher &amp; Paykel, Auckland, New Zealand ).&#xD;
&#xD;
      All preterm infants with respiratory distress will follow the following steps for neonatal&#xD;
      resuscitation&#xD;
&#xD;
        1. All infants will receive initial care including providing warmth, clearing the airway,&#xD;
           and drying and stimulating the infant.&#xD;
&#xD;
        2. After the initial steps, pulse oximetry will be initiated to determine oxygen saturation&#xD;
           and to guide the required FIO2.&#xD;
&#xD;
        3. Infants in the intervention groups will receive a single single maneuver of sustained&#xD;
           lung inflation with the first breath according to the study group.&#xD;
&#xD;
        4. Continuous positive airway pressure at a pressure of 5 cm H2O and FIO2 of 30% will be&#xD;
           delivered to infants in the control group immediately after initial steps of&#xD;
           resuscitation and to all infants in the intervention groups after the single maneuver of&#xD;
           sustained lung inflation.&#xD;
&#xD;
        5. Positive pressure ventilation will be provided uring the T-piece resuscitator if the&#xD;
           infant has an inadequate respiratory effort or a heart rate &lt;100 beats per minute at a&#xD;
           rate of 40 to 60 times per minute for 30 seconds, after which the heart rate is&#xD;
           measured.&#xD;
&#xD;
        6. Oxygen therapy will be titrated to keep a pre-ductal saturation between 90-95%.&#xD;
&#xD;
        7. Endotracheal intubation will be provided if positive pressure ventilation is&#xD;
           ineffective, prolonged apnea, or chest compression is required.&#xD;
&#xD;
        8. Chest compression will be required if the infant's heart rate remains &lt;60 bpm despite&#xD;
           adequate ventilation for 30 seconds.&#xD;
&#xD;
        9. Surfactant will be administered to preterm infants requiring a fraction of inspired&#xD;
           oxygen of 40 percent or higher to maintain oxygen saturation above 90 percent or remain&#xD;
           apneic.&#xD;
&#xD;
       10. Mechanical ventilation will be initiated for preterm infants with respiratory acidosis&#xD;
           documented by an arterial pH &lt;7.2 and PaCO2 &gt;60 to 65 mmHg, hypoxia documented by an&#xD;
           arterial PaO2 &lt;50 mmHg despite FiO2 exceeds 40 percent on nasal continuous positive&#xD;
           airway pressure, or severe apnea.&#xD;
&#xD;
      The primary outcome of the study will be the need for endotracheal intubation in the delivery&#xD;
      room.&#xD;
&#xD;
      Secondary outcomes include the need for surfactant therapy, the need for endotracheal&#xD;
      intubation and mechanical ventilation within 72 hours of birth, the duration of mechanical&#xD;
      ventilation and oxygen support, development of air leak syndromes, length of hospital stay,&#xD;
      bronchopulmonary dysplasia, necrotising enterocolitis, intraventricular haemorrhage,&#xD;
      retinopathy of prematurity, and neonatal mortality before hospital discharge,.&#xD;
&#xD;
      Broncho alveolar lavage will be performed to endotracheally intubated infants enrolled in&#xD;
      this study to measure the level of IL-10 as a lung inflammatory marker immediately after&#xD;
      birth (basal) then 12 hours after birth (follow up).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The need for endotracheal intubation in the delivery room</measure>
    <time_frame>One hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The need for mechanical ventilation</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need of surfactant</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal mortality</measure>
    <time_frame>90 days</time_frame>
    <description>Death before hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Broncho Pulmonary Dysplasia ( BPD )</measure>
    <time_frame>90 days</time_frame>
    <description>Requirement for oxygen therapy more than 30% by 36 weeks corrected gestational age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-Ventricular Hemorrhage ( IVH )</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinopathy of Prematurity ( ROP )</measure>
    <time_frame>50 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necrotizing Entero Colitis ( NEC )</measure>
    <time_frame>40 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of neonatal intensive care ( NICU ) and hospital stay</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Air-leak syndrome</measure>
    <time_frame>14 days</time_frame>
    <description>Development of pneumothorax or pneumomediastinum</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Infants in this group will not receive sustained lung inflation in the delivery room and will be put immediately on CPAP at a pressure of 5 cm H2O.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High pressure for long duration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 20 cm H2O for a duration of 20 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High pressure for short duration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 20 cm H2O for a duration of 10 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low pressure for long duration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 15 cm H2O for a duration of 20 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low pressure for short duration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 15 cm H2O for a duration of 10 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sustained lung inflation in preterms (SLI).</intervention_name>
    <description>Providing a positive pulmonary ventilation with an opening lung pressure for the first breath of preterm infant for a sustained period of time</description>
    <arm_group_label>High pressure for long duration</arm_group_label>
    <arm_group_label>High pressure for short duration</arm_group_label>
    <arm_group_label>Low pressure for long duration</arm_group_label>
    <arm_group_label>Low pressure for short duration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Preterm infants with gestational age â‰¤ 32 weeks' gestation, presented with respiratory&#xD;
        distress syndrome at birth&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. - Preterm infants with no manifestations of respiratory distress syndrome at birth.&#xD;
&#xD;
          2. - Presence of major congenital malformation (dysmorphic features or anomalies&#xD;
             incompatible with life) .&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Day</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mansoura University Children Hospital</name>
      <address>
        <city>Mansoura</city>
        <state>El Dakahlya</state>
        <zip>35111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>July 22, 2016</study_first_submitted>
  <study_first_submitted_qc>July 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2016</study_first_posted>
  <last_update_submitted>April 1, 2018</last_update_submitted>
  <last_update_submitted_qc>April 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University Children Hospital</investigator_affiliation>
    <investigator_full_name>Nehad Nasef</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Respiratory distress syndrome</keyword>
  <keyword>Sustained lung inflation</keyword>
  <keyword>Delivery room</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

